Quick Summary

Mugwort (Artemisia vulgaris) is a widely known herb with a long history of traditional medicinal use across Chinese, Hindu, and European systems. It contains essential oils, flavonoids, and sesquiterpene lactones which have demonstrated antioxidant, hepatoprotective, antispasmodic, antinociceptive, estrogenic, cytotoxic, antibacterial, and antifungal activities in laboratory studies. Clinical evidence primarily relates to moxibustion—a traditional therapy using burning Artemisia vulgaris—which has been studied for conditions including depressive symptoms post-stroke and correction of breech presentation in pregnancy. The herb also shows potential insecticidal activity against mosquitoes and antimicrobial effects in vitro. However, human clinical trial evidence is limited and often constrained by methodological issues.

What is it?

Mugwort is a perennial herb native to temperate regions of Europe, Asia, and North Africa. It has been traditionally used for various medicinal purposes and is commonly employed in moxibustion therapy in Traditional Chinese Medicine. The plant contains numerous bioactive compounds contributing to its diverse pharmacological properties.

Traditional Uses

  • Treatment of digestive and menstrual disorders
  • Use in moxibustion for various ailments such as pain relief and promotion of circulation
  • Correction of breech fetal presentation during pregnancy
  • Management of emotional and neurological conditions post-stroke
  • Antimicrobial and insecticidal applications

Active Compounds

Mugwort contains essential oils, flavonoids, and sesquiterpene lactones, which are believed to contribute to its antioxidant, antispasmodic, and antimicrobial properties, among others.

Potential Benefits with Evidence Levels

  • Adjunctive therapy for poststroke depression (Moderate evidence): A meta-analysis of 12 randomized controlled trials (RCTs) involving 819 participants showed that moxibustion with Artemisia vulgaris significantly reduced depression scores and increased clinical response rates compared to controls. Further large, high-quality studies are needed.
  • Correction of breech presentation in pregnancy (Moderate evidence): Systematic reviews and meta-analyses found that moxibustion at acupuncture point BL67 using mugwort improved cephalic presentation rates, especially in Asian populations, with low to moderate certainty of evidence.
  • Treatment of cancer-related fatigue (Low to Moderate evidence): Reviews including acupuncture and moxibustion suggest potential benefits for managing cancer-related fatigue, but the supporting studies have generally low methodological quality.
  • Management of breast cancer-related lymphedema (Low to Moderate evidence): Meta-analysis of 14 RCTs indicated that acupuncture combined with moxibustion may reduce arm circumference, improve lymphedema indexes, increase shoulder range of motion, and reduce pain and swelling.
  • Treatment of knee osteoarthritis (Low to Moderate evidence): Meta-analyses suggest moxibustion may reduce bodily pain and symptoms associated with knee osteoarthritis, although studies showed variability and limited quality.
  • Treatment of irritable bowel syndrome with diarrhea predominance (Low evidence): Moxibustion reportedly improved global and IBS-D specific symptoms compared to pharmacological treatments in a meta-analysis; however, studies were low quality with methodological limitations.
  • Antimicrobial activity against bacteria and fungi (Preclinical/In vitro evidence): Extracts and essential oils demonstrate antimicrobial and antifungal effects against multiple pathogens, including multidrug-resistant strains, though clinical data are lacking.
  • Mosquito control (Preclinical/In vitro evidence): Laboratory studies showed efficacy of mugwort extracts against various developmental stages of Aedes aegypti mosquitoes, suggesting possible use as a bioinsecticide.

Side Effects

Few mild adverse effects have been reported in moxibustion studies, including nausea, unpleasant odor, minor abdominal discomfort, and uterine contractions. Due to limited and inconsistent reporting, the complete safety profile of mugwort, particularly direct herbal use, remains unclear.

Drug Interactions

No robust clinical evidence is currently available regarding drug interactions with Artemisia vulgaris or moxibustion therapy. Caution is advised when combining mugwort with other treatments.

Who Should Avoid It

Specific contraindications are not well established due to limited clinical trial data. Pregnant and breastfeeding women should use mugwort or moxibustion cautiously and under professional supervision, despite some evidence supporting its use for breech correction. Individuals with allergies to related plants or with certain medical conditions should consult a healthcare provider before use.

Evidence Limitations

Current clinical evidence is limited by small sample sizes, heterogeneity in study design, inadequate blinding, poor reporting of interventions and adverse effects, and a lack of standardized protocols. Many studies derive from Asian populations, which may limit generalizability. There is a clear need for large-scale, high-quality, multicenter randomized controlled trials with standardized administration of mugwort and moxibustion, including thorough safety assessments.

References

Last Reviewed

June 2024

Disclaimer: This information is provided for educational purposes only and is not intended as medical advice. Mugwort and related therapies have been studied but are not guaranteed for safety or effectiveness. Always consult a qualified healthcare professional before starting any new treatment or therapy, especially if you have pre-existing health conditions or are pregnant or breastfeeding.